Lung Biotechnology Competitors and Similar CompaniesClear all

Lung Biotechnology's competitors and similar companies include TFF Pharmaceuticals, Savara and Cipla.

	Lung Biotechnology Lung Biotechnology is a company using biotechnology to design therapies for pulmonary arterial hypertension and other fatal lung diseases.	TFF Pharmaceuticals TFF Pharmaceuticals is a biopharmaceutical company focused on developing drug products based on the Thin Film Freezing (TFF) technology platform.	Savara Savara (also known as Savara Pharmaceuticals) is an orphan lung disease company.	Cipla Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.
Founding Date	Founding Date 2006	Founding Date 2018	Founding Date 1995	Founding Date 1935
Type	Type Private	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma platform	Tags Healthcare drug development medtech nanotech pharma	Tags Healthcare biotech drug development pharma
Locations	Locations Silver Spring, US HQ	Locations Austin, US HQ	Locations Austin, US HQ Hørsholm, DK	Locations Mumbai, IN HQ Melbourne, AU Antwerpen, BE São Paulo, BR São Paulo, BR Unterhaching, DE Nairobi, KE see more
Employees	Employees N/A	Employees 1927% increase	Employees 2827% increase	Employees 27,764
Valuation ($)	Valuation ($) N/A	Valuation ($) 8.5 m	Valuation ($) 605.7 m	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $733.9k (FY, 2023)	Revenue (est.) N/A	Revenue (est.) ₹277.1b (FY, 2026)
Net income	Net income N/A	Net income ($21.2m) (FY, 2023)	Net income ($118.8m) (FY, 2025)	Net income ₹38.7b (FY, 2026)
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 22.3m	Total funding raised $ 116.1m	Total funding raised N/A